Company record
Jaguar Health, Inc. develops plant‑based, sustainably derived prescription pharmaceuticals aimed at addressing chronic gastrointestinal conditions. Its product portfolio includes therapies for HIV‑associated diarrhea and for gastrointestinal symptoms that arise from cancer treatments. In the veterinary sector, the company offers a formulation that mitigates chemotherapy‑induced diarrhea in dogs. Jaguar Health’s strategic emphasis is on creating non‑opioid solutions for gastrointestinal distress across both human and animal patients, and it supplies these products to the healthcare and veterinary markets.
This directory record does not yet have a linked material-flow brief.